Skip to main content
Font Size
CUHK Innoport CUBIC Zine

Invitation for expression of interest (EOI)

Self-therapeutic nanoparticles alleviate peripheral neuropathic pain

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 7 Jul 2026] The Technology Neuropathic pain is a highly prevalent...

A self-therapeutic nanoparticle for enhanced topical delivery to skin keratinocytes and treating psoriasis

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 7 Jul 2026] The Technology Psoriasis is a chronic, noncommunicable...

A novel uniform staining method

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 15 May 2026] The Technology This invention describes a method...

A tissue Labelling method for general morphology for clinical use

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 5 March 2026] The Technology The invention describes a method...

Prodrug of Green Tea Epigallocatchin-3-Gallate (Pro-EGCG) as a Potent Anti-Angiogenesis Agent for Endometriosis

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 26 February 2026] The Technology The invention relates to the...

Methods to redirect therapeutic immune cells to the bone marrow and uses thereof

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 24 December 2025] We are inviting expressions of interest (EoI)...

Noninvasive markers in maternal plasma for the prediction of pregnancy-associated complications

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 1 August 2025] We are inviting expressions of interest (EoI) for...

Repeated Low-Level Red-Light Therapy Device

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 1 August 2025] We are inviting expressions of interest (EoI) for...

Aptamers targeting to EBV-associated malignancies and their applications in cancer imaging and therapies

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 23rd June 2025] We are inviting expressions of interest (EoI)...

An non-destructive antigen retrieval method with mild conditions for 3D histology

[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 22 May 2025]  We are inviting expressions of interest (EoI)...